1. Home
  2. RLAY vs CCO Comparison

RLAY vs CCO Comparison

Compare RLAY & CCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLAY
  • CCO
  • Stock Information
  • Founded
  • RLAY 2015
  • CCO 1995
  • Country
  • RLAY United States
  • CCO United States
  • Employees
  • RLAY N/A
  • CCO N/A
  • Industry
  • RLAY Biotechnology: Biological Products (No Diagnostic Substances)
  • CCO Advertising
  • Sector
  • RLAY Health Care
  • CCO Consumer Discretionary
  • Exchange
  • RLAY Nasdaq
  • CCO Nasdaq
  • Market Cap
  • RLAY 576.1M
  • CCO 576.2M
  • IPO Year
  • RLAY 2020
  • CCO 2005
  • Fundamental
  • Price
  • RLAY $3.63
  • CCO $1.24
  • Analyst Decision
  • RLAY Strong Buy
  • CCO Buy
  • Analyst Count
  • RLAY 11
  • CCO 4
  • Target Price
  • RLAY $18.40
  • CCO $1.88
  • AVG Volume (30 Days)
  • RLAY 1.6M
  • CCO 5.1M
  • Earning Date
  • RLAY 08-05-2025
  • CCO 08-06-2025
  • Dividend Yield
  • RLAY N/A
  • CCO N/A
  • EPS Growth
  • RLAY N/A
  • CCO N/A
  • EPS
  • RLAY N/A
  • CCO N/A
  • Revenue
  • RLAY $7,679,000.00
  • CCO $1,512,570,000.00
  • Revenue This Year
  • RLAY $14.31
  • CCO $5.10
  • Revenue Next Year
  • RLAY N/A
  • CCO $3.29
  • P/E Ratio
  • RLAY N/A
  • CCO N/A
  • Revenue Growth
  • RLAY N/A
  • CCO 14.28
  • 52 Week Low
  • RLAY $1.78
  • CCO $0.81
  • 52 Week High
  • RLAY $10.72
  • CCO $1.88
  • Technical
  • Relative Strength Index (RSI)
  • RLAY 63.22
  • CCO 64.75
  • Support Level
  • RLAY $3.10
  • CCO $1.15
  • Resistance Level
  • RLAY $3.75
  • CCO $1.20
  • Average True Range (ATR)
  • RLAY 0.23
  • CCO 0.05
  • MACD
  • RLAY 0.03
  • CCO 0.01
  • Stochastic Oscillator
  • RLAY 84.42
  • CCO 100.00

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

Share on Social Networks: